Adaptive Biotechnologies Corporation (ADPT) vs Sotera Health Company (SHC)
Adaptive Biotechnologies Corporation and Sotera Health Company are both Diagnostics & Research companies. Sotera Health Company is the larger, with a market value of $5.3B against $4.7B — 1.1× the size. Adaptive Biotechnologies Corporation has negative trailing earnings, so its P/E is not meaningful; Sotera Health Company trades at 32.1×. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 50.1% against 8.15%. Sotera Health Company has the higher net margin (13.4% vs −20.7%) and the higher return on invested capital (9.82% vs −16.6%). Across the 18 metrics below, Sotera Health Company leads on 13 and Adaptive Biotechnologies Corporation on 5.
Valuation
Profitability
| Metric | ADPT | SHC | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 75.57% | 54.97% | 50.89% |
| Operating margin | (12.16%) | 32.82% | (8.57%) |
| Net margin | (20.73%) | 13.44% | (6.37%) |
| Free cash flow margin | (7.80%) | 9.27% | 0.00% |
| Return on equity | (38.68%) | 27.78% | (2.92%) |
| Return on assets | (11.23%) | 5.01% | (6.71%) |
| Return on invested capital | (16.57%) | 9.82% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack